FDA Inspection 1150511 — Akebia Therapeutics, Inc.
The FDA completed an inspection of Akebia Therapeutics, Inc. on Aug 12, 2021 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 12, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Waltham, MA (United States)
Additional details
Sponsor, Contract Research Organization